McKinsey & Company’s Conduct and Conflicts at the Heart of the Opioid Epidemic

Meeting Notes: 
The hearing will convene in room 2154 of the Rayburn House Office Building and over Zoom, which has been approved by the House.
Date: 
Wednesday, April 27, 2022 - 10:00am
Location: 
Rayburn House Office Building, Washington, DC 20515
McKinsey & Company’s Conduct and Conflicts at the Heart of the Opioid Epidemic

Chairwoman Carolyn B. Maloney's Opening Statement [PDF]

On Wednesday, April 27, 2022, at 10:00 a.m. ET, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, will hold a hearing to examine the key role played by McKinsey in the opioid epidemic, a public health crisis that has killed half a million Americans and continues to claim tens of thousands of lives every year. 

 

The hearing will examine the findings of the Committee’s interim staff report that revealed McKinsey consultants frequently worked on Food and Drug Administration (FDA) contracts while also working for opioid manufacturers such as Purdue Pharma, and failed to disclose these conflicts of interest to the FDA—in apparent violation of contract requirements and federal law.  The report also highlighted evidence that McKinsey used its government consulting work to solicit more business from opioid manufacturers and tried to influence government officials, including the Trump Administration’s Secretary of Health and Human Services Alex Azar, to advance the interests of its private sector opioid clients.

 

The Committee’s investigation aims to uncover the full scope of McKinsey’s conflicts of interest and other abusive practices in order to strengthen federal contracting laws and increase transparency in consulting projects for the federal government.  To date, McKinsey has failed to fully cooperate with the Committee’s investigation and has refused to provide basic information about certain clients and the work McKinsey did for them.   

WITNESSES

The Honorable Maura Healey

Attorney General

Commonwealth of Massachusetts

 

In Joint Testimony with

Ms. Gillian Feiner

Senior Enforcement Counsel

Massachusetts Attorney General’s Office

 

Mr. Bob Sternfels

Global Managing Partner

McKinsey & Company

 

Professor Jessica Tillipman

Assistant Dean for Government Procurement Law Studies

George Washington University Law School

 

Mr. Uttam Dhillon

Chair, Regulatory Defense, Compliance & White Collar Practice Group

Michael Best & Friedrich LLP

 

Issues: 
117th Congress